Calculate your SIP ReturnsExplore

Markets Turn Optimistic for Godrej Consumer: Decoding The FMCG Powerhouse

25 April 20243 mins read by Angel One
Market bullish on GLPC post-UBS target hike, after Goodknight Agarbatti launches with RNF, aiming for market dominance with safety and affordability.
Markets Turn Optimistic for Godrej Consumer: Decoding The FMCG Powerhouse
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

Godrej Consumer Products Limited(GCPL), a publicly traded entity with a market capitalization of Rs.1,23,817 Crores, operates within the fast-moving consumer goods (FMCG) sector. The company specializes in the manufacturing and marketing of a wide range of household and personal care products.

Markets Bullish

On April 25, the stock of Godrej Consumer Products Limited rose by more than 1% to reach Rs.1,225. This increase followed UBS’s upward revision of its target price, citing potential revenue boosts from new product launches. UBS, an international investment banking company, reaffirmed its ‘buy’ recommendation and raised the target price from Rs.1,200 to Rs.1,450. The revised target indicates a 19.5% increase.

Star Product

In February, Godrej Consumer Products Limited introduced Goodknight Agarbatti, which stands out as India’s inaugural legally approved anti-mosquito incense sticks. These innovative incense sticks utilize a unique compound named Renofluthrin (RNF), and GCPL has collaborated with a manufacturer to exclusively develop this ingredient for their products. The anti-mosquito incense sticks market currently stands at Rs.1,200 crore and faces competition from various unorganized players. GCPL aims to seize market share within this category as consumers are inclined towards purchasing the safer option offered by Godrej. Additionally, Goodknight Agarbatti is priced similarly to competitors, at Rs.12 in north India and Rs.10 in south India, making it an attractive choice for consumers seeking safety and affordability.

Unique RNF Formulation

In the home insecticides sector, companies are required to obtain approval from the Central Insecticides Board (CIB) for their formulations or molecules before marketing their products. GCPL has successfully registered Renofluthrin(RNF) with the CIB, enabling the company to incorporate it into their incense sticks for use in the market. Analysts project that GCPL’s unique access to the formulation of RNF, along with its extensive distribution channels, will facilitate the company in expanding its market share within the anti-mosquito incense sticks segment. This category contributes around 30-40% of GCPL’s overall revenues. While the company’s sales have shown steady growth with a compound annual growth rate (CAGR) of 10% over the past three years, its profit growth has been relatively decreased, registering a CAGR of only 3% during the same period.

Conclusion: GCPL’s dynamic approach to and market strategy emphasizes its plans to expand further in the FMCG sector. By introducing products like Goodknight Agarbatti and securing regulatory approvals, the company has cracked the code by targeting a widely sold product from the unorganized sector, capturing a significant market share. With a good reputation, it promises safety to the consumers with a competitive pricing because of this, GCPL seems poised for continued growth ahead.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.

Open Free Demat Account!

Enjoy Zero Brokerage on Equity Delivery

Join our 2 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy Zero Brokerage on Equity Delivery

Get the link to download the App

Send App Link

Enjoy Zero Brokerage on
Equity Delivery